The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD) test for evaluating amyloid pathology ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Read this article to find out why and how steroids such as dexamethasone are used – and withdrawn – in palliative care.

Introduction Many women need to use medications during breastfeeding. Very few medications have been adequately monitored, tested and labelled with safety information for this use. Prednisolone is one ...

Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...

Cholesterol ratios are sometimes used to provide more detail on the balance between different types of blood fats and to evaluate risk of developing heart disease. This ratio is used in Australia ...

It works by measuring two proteins in blood plasma: pTau217 and beta-amyloid 1-42. A ratio of those proteins tends to correlate with the occurrence or absence of amyloid plaques in the brain ...

Research shows MMA athletes experience greater blood changes than boxers, highlighting the need for specific recovery ...

Participants in the highest BGAT quartile of this study had a hazard ratio for VTE risk of 2.12 compared with those in the lowest BGAT quartile after adjusting for age and sex characteristics.